Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2024 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.16 EPS, expectations were $-0.16. Operator: Good morning, and welcome to Y- …